Results from Phase 1/2 Study of Kelun-Biotech's TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) in Patients with Unresectable Locally Advanced or Metastatic Solid Tumors Refractory to Standard Therapies, Published in Journal of Hematology & Oncology
CHENGDU, China, June 10, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") today announced that results from the Phase 1/2 study (KL264-01/MK-2870-001) evaluating the novel TROP2 antibody drug conjugate (ADC)...
Asia Tech x Singapore 2025 Recap
SINGAPORE, June 10, 2025 /PRNewswire/ -- At the recent ATxSummit, the apex event of Asia Tech x Singapore (ATxSG) 2025, organised by the Infocomm Media Development Authority of Singapore (IMDA), key global and regional efforts around AI, LLM models,...
Heungkong, Panasonic and Tantron Unveil Breakthrough in Forest-Ecology-Inspired Indoor Bionic Technology
GUANGZHOU, China, June 10, 2025 /PRNewswire/ -- Heungkong Group, Panasonic Electric, and Tantron Technology have announced the mid-stage outcomes of their collaborative innovation, the "8 Constants+ Forest Environment System," on World Environment...
Planet Green Advances AI-Powered Early Mental Health Intervention for Youth in Post-Pandemic Canada
NEW YORK, June 9, 2025 /PRNewswire/ -- Planet Green Holdings Corp. ("Planet Green", the "Company") (NYSE American: PLAG) announced that its subsidiary Fast Approach Inc., ("Fast Approach"), a leader in applied AI technology, today announced a...
RayNeo Launches X3 Pro: Redefining AR with Cutting-Edge Tech
SHENZHEN, China, May 28, 2025 /PRNewswire/ -- RayNeo, a trailblazer in consumer AR technology, today unveiled its revolutionary product lineup at the "See the Extraordinary" launch event, marking China's ascendancy in the global XR arena. The...
Eisai to Present E7386, Co-created by PRISM BioLab and Eisai, at the ASCO (American Society of Clinical Oncology) Annual Meeting
Abstract Released for E7386, Co-Developed Through Collaborative Research Between Eisai and PRISM TOKYO, May 23, 2025 /PRNewswire/ -- PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule...
Baidu to Hold Annual General Meeting on June 27, 2025
BEIJING, May 8, 2025 /PRNewswire/ -- Baidu, Inc. ("Baidu" or the "Company") (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)), a leading AI company with strong Internet foundation, today announced that it will hold its annual general...
Manulife Releases 2024 Sustainability Report and Public Accountability Statement
Report shares firm's continued progress toward generating long-term value for its business, customers, communities, and shareholders C$ unless otherwise stated TSX/NYSE/PSE: MFC SEHK: 945 TORONTO, May 7, 2025 /PRNewswire/ -- Manulife today released...
M31 Collaborates with TSMC to Advance 2nm eUSB2 IP Innovation
HSINCHU, April 24, 2025 /PRNewswire/ -- M31 Technology Corporation (M31), a global provider of silicon intellectual property (IP), today announced that its eUSB2 PHY IP has achieved silicon-proven status on TSMC's 3nm process and has successfully...
Aquilius Investment Partners Chooses SS&C for Fund Administration
Appointment advances SS&C's growth strategy in Asia-Pacific Private Markets WINDSOR, Conn., April 23, 2025 /PRNewswire/ -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that Aquilius Investment Partners, a Singapore-based...